Roche Looks to FCB for $30 Mil. Account

The countdown to Brandweek is on! Join us, Sept. 12-16, to identify new growth opportunities, solve challenges and connect with power players. View the lineup and secure your pass.

NEW YORK Interpublic Group’s Foote Cone & Belding is poised to assume direct-to-consumer advertising chores from pharmaceutical company Hoffman-La Roche for two drugs to treat hepatitis C, sources said. Annual media spending for upcoming campaigns could exceed $30 million, sources said.

FCB in New York competed in a review that included three other undisclosed agencies.

AW+

WORK SMARTER - LEARN, GROW AND BE INSPIRED.

Subscribe today!

To Read the Full Story Become an Adweek+ Subscriber

View Subscription Options

Already a member? Sign in